CD8A and lung cancer: A prospective study reported that an increased frequency of activated CD8+CD38+ MAIT cells in peripheral blood is significantly associated with shorter progression‐free survival (PFS) in lung cancer patients, and this population coincides with elevated serum proinflammatory factor levels, suggesting that it may serve as an early warning indicator for disease progression.